Ascletis is an innovative R&D driven biotech with two commercial products and listed on Hong Kong Stock Exchange (Ascletis, 1672.HK). Ascletis’ mission is to address unmet medical needs in three therapeutic areas: viral, cancer and fatty liver diseases. Led by a management team with deep expertise and a proven track record, Ascletis has developed a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization.

Biotechnology

Ascletis

Jinzi J. Wu

Judy Wu

Handan He

Jiong Gu

Lin Hua

Yizhen Wei

Ascletis' Leadership Team includes Yuemei Yan and 3 others.

About

People (4)

Handan He

Jinzi J. Wu

Judy Wu

Yuemei Yan

Jobs